CN Patent

CN101314579B — 无水帕拉米韦晶体及其药物组合物

Assigned to TIANJIN TAIPU PHARMACEUTICAL Co.,Ltd. · Expires 2010-11-24 · 15y expired

What this patent protects

本发明涉及无水帕拉米韦晶体化合物以及该晶体化合物的制备方法，同时本发明进一步公开了含有无水帕拉米韦晶体化合物的药物组合物，以及该组合物在制备治疗流感病毒及禽流感病毒药物中的应用。

USPTO Abstract

本发明涉及无水帕拉米韦晶体化合物以及该晶体化合物的制备方法，同时本发明进一步公开了含有无水帕拉米韦晶体化合物的药物组合物，以及该组合物在制备治疗流感病毒及禽流感病毒药物中的应用。

Drugs covered by this patent

benzgalantamine-gluconate (BENZGALANTAMINE GLUCONATE)

Patent Metadata

Patent number: CN101314579B
Jurisdiction: CN
Classification: —
Expires: 2010-11-24
Drug substance claim: No
Drug product claim: No
Assignee: TIANJIN TAIPU PHARMACEUTICAL Co.,Ltd.
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.